Organization
Noorik Biopharmaceuticals
2 clinical trials
Clinical trial
A Multi-Centre, Randomised, Open-Label, Phase II Study of Ambrisentan in Patients With Hepatorenal SyndromeStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Ambrisentan in Patients With Severe COVID-19Status: Terminated, Estimated PCD: 2023-02-27